RxSight, Inc. (RXST) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 121.08M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 28.71M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $121.08M | $28.71M | (m) |
| 2026-03-31 | $98.18M | $127.48M | $29.30M | 77.02% |
| 2025-12-31 | $103.01M | $134.48M | $31.47M | 76.60% |
| 2025-09-30 | $106.53M | $142.09M | $35.55M | 74.98% |
| 2025-06-30 | $107.53M | $147.06M | $39.53M | 73.12% |
| 2025-03-31 | $106.59M | $148.31M | $41.72M | 71.87% |
| 2024-12-31 | $98.94M | $139.93M | $40.98M | 70.71% |
| 2024-09-30 | $87.81M | $128.29M | $40.48M | 68.44% |
| 2024-06-30 | $76.32M | $115.18M | $38.86M | 66.26% |
| 2024-03-31 | $64.08M | $101.10M | $37.02M | 63.39% |
| 2023-12-31 | $53.77M | $89.08M | $35.31M | 60.36% |
| 2023-09-30 | $43.53M | $76.58M | $33.05M | 56.84% |
| 2023-06-30 | $35.16M | $67.00M | $31.84M | 52.47% |
| 2023-03-31 | $27.93M | $57.55M | $29.62M | 48.54% |
| 2022-12-31 | $21.33M | $49.01M | $27.68M | 43.52% |
| 2022-09-30 | $16.77M | $41.34M | $24.57M | 40.58% |
| 2022-06-30 | $12.76M | $34.51M | $21.75M | 36.97% |
| 2022-03-31 | $7.16M | $28.05M | $20.89M | 25.52% |
| 2021-12-31 | $4.52M | $22.59M | $18.08M | 19.99% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $1.71M | $14.68M | $12.97M | 11.62% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |